Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,522,681
+$888,413 QoQ
Shares Held
65,660
-8.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#696
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $175,268,765 across 14 Drug Manufacturers - General names. ABBV ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
32,277 | $38,714,004 | |
| 2 | JNJ |
Johnson & Johnson
|
114,657 | $29,119,437 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
320,925 | $18,491,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
140,968 | $18,114,387 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
65,660 | $16,522,681 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
104,200 | $13,164,627 | |
| 7 | PFE |
Pfizer Inc
|
411,666 | $9,912,916 | |
| 8 | AMGN |
Amgen Inc
|
26,885 | $9,735,596 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,522,681 | 65,660 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $15,634,268 | 71,885 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $15,576,619 | 68,172 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,265,809 | 48,656 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $7,797,524 | 42,008 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $7,971,188 | 38,045 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,017,988 | 33,866 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $6,709,383 | 33,975 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,255,544 | 30,641 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $5,011,574 | 27,521 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $4,343,034 | 28,025 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $5,115,739 | 34,320 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,315,031 | 24,605 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,195,415 | 26,325 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,973,505 | 24,587 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $2,806,062 | 20,908 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $4,662,649 | 30,443 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $4,491,257 | 27,705 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,055,030 | 22,563 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,169,589 | 20,113 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $2,101,637 | 18,658 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $683,409 | 6,315 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $594,789 | 5,551 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $194,975 | 2,226 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $170,538 | 1,737 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $120,075 | 1,576 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||